Sunny Pharmtech Current Assets

Sunny Pharmtech posts a current assets of $270M as of June 2026. That compares with $320M in the prior-year period — down 15.1% year over year. Comparing that reading with peers and prior periods is usually more useful than looking at the number in isolation.

In the prior comparable period, Sunny Pharmtech's current assets was $320M. The latest reading is $270M — a 15.1% year-over-year decrease (period ending June 2026). Use the history and growth charts on this page for a longer lookback.

Current Assets is one piece of Sunny Pharmtech's financial statement story. At $270M, it should be interpreted next to related metrics — for example revenue with costs, assets with liabilities, or income with margins. Stockcircle links those related pages so you can move from this number to the surrounding context quickly.

Context for 6676.TWO's current assets usually means three checks: (1) trend versus prior periods, (2) level versus peers, and (3) consistency with growth and profitability. This page covers the first two; Sunny Pharmtech's other metric pages and overview cover the third.

Judging Sunny Pharmtech against Healthcare peers is usually better than using a market-wide rule of thumb. Business models inside Healthcare are more comparable, which makes gaps in current assets easier to interpret. Start with $270M here, then scan peer and history charts to see if the gap is persistent.